Skip to main content
. 2014 Mar;99(3):489–496. doi: 10.3324/haematol.2013.094318

Figure 3.

Figure 3.

OS according to HCV prognostic score (HPS) categories in the subgroup of patients treated with R-CHOP (A); PFS according to HCV prognostic score (HPS) categories in the subgroup of patients treated with R-CHOP (B); OS according to HCV prognostic score (HPS) categories in the subgroup of patients treated with CHOP (C); PFS according to HCV prognostic score (HPS) categories in the subgroup of patients treated with CHOP (D).